British journal of diabetes impact factor, 전자자료검색 | 단국대학교 퇴계기념도서관
Changes in diabetes-related complications in the United States, — N Engl J Med. No relationship between cerebral blood british journal of diabetes impact factor velocity and cerebrovascular reserve capacity and contemporaneously measured glucose and insulin concentrations in diabetes mellitus.
Acta Diabetol. Cell Rep. Twenty-third edn. J R Soc Interface ; Biochemistry and molecular cell biology of diabetic complications. Nature ; — The endothelial border to health: Mechanistic evidence of the hyperglycemic culprit of inflammatory disease acceleration. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Eur Heart J. Vascular complications of diabetes: mechanisms of injury and protective factors.
Cell Metab. Banting memorial lecture reversing the twin cycles of type 2 diabetes.
Központi Könyvtár - Egyetemi Publikációk
Diabet Med. Diabetic dyslipidaemia and the atherosclerosis. Circulation ; — Oxidative stress and diabetic complications. Circ Res. Endothelial british journal of diabetes impact factor — a major mediator of diabetic vascular disease. Biochim Biophys Acta ; — Pathogenesis of diabetic cerebral vascular disease complication.
World J Diabetes ; 6: 54— Diabetes mellitus and vascular endothelial dysfunction: current perspectives. Curr Vasc Pharmacol. Action des acides aminés sur les sucres: formation des mélanoïdines par voie méthodique.
Nav view search
C R Acad Sci Paris. Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms. Mol Metab. Role of reactive oxygen species-mediated signaling in aging. Antioxid Redox Signal. Oxidative stress and cardiovascular risk: obesity, diabetes, smoking, and pollution: Part 3 of a 3-part series. J Am Coll Cardiol.
The role of oxidative stress in the development of diabetic neuropathy. Endothelial control of vasomotor tone: the kidney perspective. Semin Nephrol. Balancing prostanoid activity in the human vascular system. Trends Pharmacol Sci.
Abnormal Rho-associated kinase activity contributes to the dysfunctional myogenic response of cerebral arteries in type 2 diabetes. Can J Physiol Pharmacol. The vulnerable blood. Coagulation and clot structure in diabetes mellitus. Hamostaseologie ; 25— Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.
You are here
Cardiovasc Diabetol. Thrombosis in diabetes: a shear flow effect? Clin Sci London. Diabetes mellitus and thrombosis. Thromb Res. Platelets and diabetes mellitus. Prostaglandins Other Lipid Mediat. Formation of methionine sulfoxide by peroxynitrite at position of von Willebrand factor inhibits its cleavage by ADAMTS A new prothrombotic mechanism in diseases associated with oxidative stress. Free Radic Biol Med. Human expression patterns: qualitative and quantitative analysis of thrombospondin-1 under physiological and pathological conditions.
J Cell Mol Med. Advances in the management of diabetic neuropathy. Minerva Med. Lancet ; — Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.
Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler Thromb Vasc Biol. Is there more to the future than suture? Physiology of the haemostasis from the clinical point of view II. A perioperatív véralvadás klinikai élettana II. Hemostasis in pregnancy: a natural model of hemostasis resuscitation in patients with massive perioperative blood loss.
Physiology of the haemostasis from the clinical point of view I. A perioperatív véralvadás klinikai élettana I. Platelets from patients with diabetes mellitus have impaired ability to mediate vasodilation.
16 Signs Your Blood Sugar Is High \u0026 8 Diabetes Symptoms
J Biol Chem. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
J Clin Endocrinol Metab.
- Diabetológus debrecen
- Kezelése kutatás diabétesz
Tissue factor and cardiovascular disease: quo vadis? Circ J. The influence of type 2 diabetes on fibrin structure and function. Diabetologia ; — Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
Biochemistry ; — Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor kezelésére használt készítmények cukor cukorbetegség 2 fok type 2 diabetic patients.